Spanish charity aims to become key reference point for breast cancer info
This article was originally published in Clinica
Executive Summary
A leading Spanish breast cancer charity has revamped its internet presence, in a bid to become a "key reference point" for the 16,000 women who are diagnosed annually with breast cancer in the country. Ascamma cites data by Google España that 85% of Spanish patients access the web as the first port-of-call for healthcare-related information and after receiving medical advice; it also claims that 20% of all Internet searches are for health-related information. The relaunched website (www.ascamma.org) has links to the national medical oncology society (SEOM) and the national association for immediate reconstructive surgery (AERMI), among other organisations; it is sponsored by Roche. Ascamma is a vocal campaigner for breast cancer screening and early diagnosis.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.